Cognitive Clarity Inc. products are research-driven. For PTI-00703® cat’s claw, the National Institute on Aging provided over $2.5 million to support Dr. Alan Snow’s research laboratory while at the University of Washington (Seattle, WA, USA). Over 29,000 hours of documented scientific research was conducted to assess the validity of PTI-00703® cat’s claw and its ingredients for potential inhibition/reduction of brain “plaques” and/or “tangles.” This resulted in 19 peer-reviewed publications and/or scientific presentations at US and international meetings.
Over 29,000 hours of documented scientific research was conducted to assess the effects of PTI-00703® cat’s claw and its ingredients
Two of the World’s Leading Neuroscientists are Backing Percepta® and Cognitive Clarity Inc. Products
For the past 30 years, Dr. Alan Snow and Dr. Rudolph Tanzi have been at the forefront of brain aging and memory disorders. Their background and knowledge is unmatched by any other brain nutraceutical Company in the world. These two innovators who have spent so much of their lives in the fields of memory, cognition, and studying brain “plaques and tangles” are probably two of the most qualified neuroscientists in the world to lead this campaign of developing “Breakthrough Nutraceuticals for the Aging Brain.”
Dr. Alan Snow (Ph.D. in Pathology) is a world-renowned expert in brain aging, memory loss, Alzheimer’s disease, Parkinson’s disease, and other amyloid disorders. He is a former Research Associate Professor of Pathology at the University of Washington, where he was an Alzheimer’s Disease Research project team leader for over 10 years. His knowledge and theories about brain plaque and tangle formation as key targets for memory loss have always been at the forefront of brain aging research. He has been awarded 18 National Institute of Health (NIH) grant awards and a prestigious LEAPS award from the Michael J. Fox Foundation for Parkinson’s disease research. He has published extensively and in an inventor of over 340 issued patents (USA and Internationally) on new drugs, nutraceuticals, and screening technologies. In Feb 2019, he published a landmark 108-page paper in Scientific Reports (Nature journal) describing the discovery of PTI-00703 cat’s claw as a potent inhibitor and reducer of brain plaques, tangles, and neuroinflammation. He is also an expert in brain tangle formation that occurs following concussions and head injury, CTE (chronic traumatic encephalopathy) and TBI (traumatic brain injury).
You can listen to Dr. Snow and Mark Alyn here:
